It has not been demonstrated in controlled clinical trials that Epitalon causes hair regrowth in humans or reverses greying. The most relevant evidence is indirect: Epitalon has been studied for its effects on telomere biology, chromatin, and other cellular pathways associated with ageing, whereas hair and skin ageing involve processes such as cellular senescence, oxidative stress, a decline in stem cell activity, and changes in the extracellular matrix. Direct evidence regarding hair growth is still lacking. [1–6]
Searches regarding Epitalon hair growth, Epitalon hair, grey hair reversal, skin rejuvenation and anti-ageing effects often combine two distinct areas of evidence.
The first involves actual Epitalon research on telomerase, chromatin, aging, and cellular regulation. The second comes from general dermatological research showing that hair follicles and skin change with age through mechanisms involving stem cell exhaustion, melanocyte loss, oxidative stress, fibroblast dysfunction, and cellular senescence.
There is still a lack of direct evidence connecting these two areas of research.
No robust human study has been identified demonstrating that Epitalon increases scalp hair density, accelerates hair regrowth, reverses androgenetic alopecia, restores pigmentation to grey hair, reduces wrinkles, or improves clinically measured skin elasticity.
Does Epitalon Promote Hair Growth?
There is no direct clinical evidence that Epitalon supports hair growth in humans. Published studies on Epitalon have focused on telomerase, ageing, chromatin and neuroendocrine pathways, but no controlled studies have been conducted measuring hair count, follicle density, anagen phase length, hair shaft diameter or scalp hair regrowth following exposure to Epitalon. [1–3]
Hair growth is regulated by the hair follicle cycle, which consists primarily of the anagen, catagen and telogen phases.
Ageing can reduce the regenerative capacity of follicles, affect stem cell function and contribute to diffuse hair thinning or age-related hair loss. A 2026 European expert consensus identified stem cell exhaustion, fibrosis and immunosenescence as likely mechanisms of age-related hair loss, among others.
These mechanisms make the biology of ageing relevant to hair research.
However, biological significance is not synonymous with therapeutic efficacy.
Epitalon influenced telomerase activity and telomere length in experiments on cultured human cells. A 2003 study on fibroblasts described telomerase activation and telomere elongation, whereas a 2025 study demonstrated telomere elongation in normal human fibroblasts and mammary epithelial cells following repeated exposure to Epitalon. [2,3]
These results are sometimes extrapolated into claims that Epitalon can rejuvenate hair follicles.
However, such a conclusion goes beyond the available evidence.
None of these studies involved hair follicle stem cells, dermal papilla cells, scalp follicles, or individuals struggling with hair loss. These experiments therefore do not prove increased hair growth.
Current research on hair ageing also shows that follicle ageing involves many more processes than mere telomere shortening, including stem cell niche changes, fibrosis, inflammatory signalling and growth factor biology.
Available evidence therefore allows Epitalon to be described as a compound investigated for mechanisms related to ageing, but its direct efficacy in hair growth has not been confirmed.
Can Epitalon Reverse Grey Hair?
Currently, there is no evidence to indicate that Epitalon reverses grey hair in humans. Greying is primarily linked to the decline in the function of melanocytes and melanocyte stem cells, changes in melanogenesis, and oxidative stress. No controlled study of Epitalon has demonstrated the restoration of hair pigmentation, an increase in melanin production, or reliable repigmentation of grey scalp hair. [4–7]
Greying and hair loss are associated with ageing, but represent different biological processes.
Hair colour depends largely on the melanocytes located in the hair follicle, which produce melanin during active hair growth. Age-related greying develops when pigment production becomes insufficient, typically in connection with changes concerning melanocytes, their stem cells, melanogenesis, and oxidative stress.
Research also shows that grey hair can still grow actively. In one study of human scalp, white hair showed higher expression of several genes related to keratin and hair growth than pigmented hair.
This demonstrates an important distinction:
Hair pigmentation and hair growth are partly distinct biological traits.
Epitalon research includes findings related to the biology of ageing and oxidative stress pathways. However, no direct study has been identified measuring melanocyte stem cell behaviour, melanin production in the hair follicle, or the repigmentation of grey hair following exposure to Epitalon.
A systematic review on the pharmacological repigmentation of grey hair also failed to identify Epitalon as a confirmed pigment-restoring intervention. The authors stated that evidence regarding the actual pharmacological reversal of greying is generally limited and often relies on case reports or incidental observations.
Claims that Epitalon restores natural hair colour, reverses greying, or reactivates melanocytes should therefore not be presented as established scientific facts.
Has Epitalon Been Studied for Hair Regrowth?
No peer-reviewed study dedicated to hair regrowth following Epitalon has been identified that measured human scalp hair regrowth or follicle regeneration in a validated model of alopecia. Existing studies on Epitalon concern other biological systems, therefore claims regarding androgenetic alopecia, hair thinning or baldness remain extrapolations rather than direct research findings.
A properly designed hair regrowth study would typically analyse parameters such as:
- number of terminal hairs;
- hair density per square centimetre;
- hair shaft diameter;
- anagen to telogen ratio;
- changes in the standardised phototrichogram;
- dermal papilla activity;
- follicular miniaturisation;
- and validated ratings from researchers and participants.
No Epitalon study providing this type of data has been identified.
This distinction is particularly important in the case of androgenetic alopecia, which has a specific pathophysiology involving genetic predisposition, androgen signalling and progressive follicular miniaturisation. The general impact on pathways related to ageing does not automatically mean the reversal of these mechanisms.
The 2026 European expert consensus on hair ageing distinguished age-related alopecia from androgenetic alopecia, while acknowledging the possibility of a partial overlap in these mechanisms. The consensus also noted that, among pharmacological interventions, only minoxidil gained expert endorsement regarding age-related hair thinning, whereas novel approaches targeting the biology of ageing require further research.
This is a significantly higher level of evidence than that currently available for Epitalon.
A broader discussion of research related to ageing can be found in the article Epitalon Longevity Research: Aging, Lifespan and Geroprotection.
What Is the Proposed Link Between Ageing and Hair?
Hair ageing involves processes such as depletion of hair follicle stem cells, a decrease in melanocyte numbers, oxidative stress, cellular senescence, fibrosis and changes in growth signalling. These processes can contribute to thinning, greying and a reduced regenerative capacity of the hair. Epitalon is sometimes theoretically linked to these processes due to its experimental effect on cellular pathways associated with ageing, but such a connection has not been directly demonstrated in human hair follicles. [2–6]
Hair follicles are dynamic micro-organs containing epithelial stem cells, melanocyte stem cells, dermal papilla cells, keratinocytes and supporting connective tissue.
Many elements of this system change with age.
Reviews on hair follicle ageing describe a deterioration in the function of both the follicle stem cells and their surrounding niche.
Recent experimental studies also indicate the importance of cellular senescence. In a 2025 study, increased epidermal IGF-1 signalling in mice accelerated greying and hair loss and was associated with an increase in senescence markers and depletion of hair follicle stem cells. Similar age-related changes in IGF-1 were also observed in human skin.
Greying involves additional mechanisms related to melanocyte biology, oxidative stress and genetic regulation.
Because Epitalon has been studied in relation to telomeres, chromatin, and cell regulation associated with ageing, a theoretical link to the hair follicle ageing process can be proposed.
Before formulating a direct claim about hair growth, however, several intermediate stages would need to be demonstrated:
- Epitalon would have to reach biologically significant cells of the hair follicles;
- it would have to influence ageing pathways in those very cells;
- molecular changes would have to preserve or restore follicle function;
- and then they would have to lead to measurable improvements in human hair growth or pigmentation.
These stages have not been confirmed so far.
Does Epitalon Affect Skin Ageing?
Epitalon induced ageing-related effects in cultured human fibroblasts, including the reported activation of telomerase and elongation of telomeres. However, it has not been shown in robust clinical studies that Epitalon reduces wrinkles, increases collagen production in the dermis, improves elasticity, or visibly rejuvenates human skin. Its significance for skin ageing therefore remains primarily mechanistic rather than clinically proven. [2,3,8–10]
Dermal fibroblasts play an important role in skin ageing.
These cells maintain the extracellular matrix, including collagen-rich structures that are responsible for the mechanical strength and organisation of the dermis. With age, collagen undergoes fragmentation, fibroblast-matrix interactions deteriorate, the activity of matrix metalloproteinases may increase, and the production of new extracellular matrix components decreases.
Cellular senescence also contributes to these processes.
Senescent dermal fibroblasts can accumulate during ageing and develop a senescence-associated secretory phenotype (SASP), releasing inflammatory mediators and matrix-degrading enzymes that can further affect tissue structure.
Epitalon connects to this area of research through experiments with fibroblasts.
A 2003 study used human foetal fibroblasts in vitro and described the induction of telomerase activity along with telomere elongation. [2]
A 2025 study also used normal human fibroblasts and found significant telomere lengthening after repeated exposure to Epitalon for three weeks, associated with increased telomerase activity. [3]
These results indicate that Epitalon may influence the cellular pathway associated with fibroblast ageing.
They do not, however, prove:
- increased collagen production in human skin;
- reduction in wrinkle depth;
- improving skin elasticity;
- increase in dermis thickness;
- reversal of photoageing;
- nor any clinically visible skin rejuvenation.
Skin ageing does not depend solely on telomere length. An important role is also played by fibroblast mechanosignals, extracellular matrix fragmentation, TGF-β signalling, chronic inflammation, UV exposure, and cellular changes independent of senescence.
The link between Epitalon and skin ageing is therefore biologically interesting, but still clinically unconfirmed.
Do Before and After Photos Constitute Scientific Evidence?
No. Before and after photos can document a change in appearance, but on their own they cannot prove that Epitalon caused hair growth, restoration of pigmentation, or skin rejuvenation. Lighting, hairstyle, camera angle, hair length, cosmetics, photo editing, the natural hair cycle, and simultaneous interventions can alter appearance without demonstrating a biological effect of the treatment.
Photographs may form part of a clinical trial if they are taken under standardised conditions and combined with objective measurements.
In hair research, better methodology may include standardised positioning and lighting along with phototrichograms, hair counting, shaft diameter measurements and blinded investigator evaluation.
Skin assessments can similarly combine standardised photographs with instrumental measurements of wrinkle depth, elasticity, hydration, pigmentation or dermal structure.
Uncontrolled before-and-after photos published on the internet usually do not meet such criteria.
Important interfering factors include:
- longer or differently styled hair can appear thicker;
- grey hair can look darker in different lighting;
- hair dyeing can mimic repigmentation;
- camera exposure can alter the visible skin tone and redness;
- moisturisation can temporarily reduce the appearance of fine lines;
- medicines, cosmetics or treatments may be used concurrently;
- natural fluctuations in the hair growth cycle can alter perceived density over time.
User accounts and photographs should therefore be treated as anecdotal observations that can generate hypotheses rather than as evidence of Epitalon's effectiveness.
Scientifically valuable before-and-after comparisons require a standardised methodology and, where possible, appropriate control groups.
What Human Research Evidence Supports Claims Regarding Hair or Skin?
Direct human clinical evidence supporting the use of Epitalon for hair growth, reversing greying, or cosmetic skin rejuvenation is virtually non-existent. Human data primarily derive from cultured human cells and older clinical trials related to other areas, such as the retina or circadian rhythm biology. Claims regarding hair and skin therefore remain extrapolations rather than proven human effects. [1–3]
In the case of hair, no controlled human study of Epitalon has been identified measuring hair regrowth, scalp density, pigmentation, or outcomes related to alopecia.
In the case of skin, the data on Epitalon most directly related to human biology comes from experiments on human cells rather than cosmetic dermatology clinical trials.
A 2003 telomerase study used human foetal fibroblasts in culture. [2]
A study published in 2025 in Biogerontology analysed normal human fibroblasts along with mammary epithelial cells and tumour cell lines. [3]
None of these studies was a cosmetic dermatology study.
Epitalon has also been studied ex vivo in lymphocytes of elderly individuals, in which chromatin changes were described. These observations are relevant to research on cellular ageing, but do not prove visible skin rejuvenation.
A broader 2025 review of Epitalon summarises the significant gerontological literature, but does not establish controlled clinical evidence regarding scalp hair regrowth or cosmetic skin improvement.
The available evidence can be summarised as follows:
| Statement | Status of evidence |
|---|---|
| Epitalon alters telomere biology in human fibroblasts | Yes, in vitro [2,3] |
| Epitalon affects cellular mechanisms related to ageing | Yes, preclinically [1–3] |
| Epitalon increases hair density on the human scalp | Not set |
| Epitalon causes lost hair to regrow | Not set |
| Epitalon reverses greying | Not set |
| Epitalon restores melanocyte function | Not set |
| Epitalon increases collagen in human skin | Not clinically confirmed |
| Epitalon reduces wrinkles | Not set |
| Epitalon improves skin elasticity | Not set |
| Epitalon visibly rejuvenates the skin | Not set |
Therefore, the available evidence supports the biological plausibility of certain hypotheses rather than direct clinical confirmation.
Does Cellular Senescence Explain the Potential Impact on Hair or Skin?
Cellular senescence is an important component of both hair follicle and skin ageing, but no study has shown that Epitalon clears senescent cells or clinically reverses senescence in the human scalp or skin. Its effects on telomere-related pathways in cultured cells should not be interpreted as evidence of senolytic activity or confirmed tissue rejuvenation. [2,3,8–10]
Telomere maintenance and cellular senescence are connected, but they are not the same thing.
Cells can undergo senescence as a result of telomere shortening, but also due to oxidative stress, DNA damage, oncogenic signalling, mitochondrial dysfunction and other forms of cellular stress.
Dermatological research indicates that ageing dermal fibroblasts can acquire senescent cell characteristics and SASP signalling, potentially contributing to chronic inflammation and extracellular matrix degradation.
Hair follicle studies also indicate the role of senescence and stem cell exhaustion in age-related hair follicle functional decline.
The described effect of Epithalon on telomerase therefore relates to a single biologically significant pathway.
However, it has not been shown that Epitalon acts as a senolytic, i.e. an agent that selectively removes senescent cells.
There is also no evidence that it restores ageing human hair follicles or skin tissue to a clinically younger state.
Epitalon, Hair and Skin – Summary of Evidence
| Research question | An evidence-based response |
|---|---|
| Does Epitalon cause hair regrowth in humans? | Not demonstrated |
| Does it increase hair density? | Not demonstrated |
| Does it treat androgenetic alopecia? | Not demonstrated |
| Does it reverse grey hair? | Not demonstrated |
| Does it restore hair pigmentation? | Not demonstrated |
| Does the biology of ageing matter for hair follicles? | Yes |
| Does Epitalon affect telomere biology in fibroblasts? | Yes, in vitro [2,3] |
| Does this prove skin rejuvenation? | Not |
| Does Epitalon clinically increase collagen production? | Not set |
| Does it reduce wrinkles or improve elasticity? | Not set |
| Do before and after photos constitute sufficient evidence? | Not |
| Are there controlled human hair or skin studies? | No robust studies were identified |
Frequently Asked Questions about Epitalon, Hair and Skin
Does Epitalon Cause Hair Growth?
There is no controlled evidence in humans showing that Epitalon increases scalp hair growth or density. Its effect on cellular processes related to ageing, including the reported telomerase activity in cultured fibroblasts, creates only a theoretical link to tissue ageing and does not prove the stimulation of human hair follicles or the treatment of hair loss. [2,3]
Does Epitalon Cause Lost Hair to Grow Back?
Hair regrowth has not been demonstrated in a dedicated clinical trial of Epitalon. No robust evidence has been identified indicating the restoration of miniaturised follicles, an increase in terminal hair count, or the reversal of androgenetic or age-related alopecia following exposure to Epitalon.
Can Epitalon Reverse Grey Hair?
No controlled study has shown the reversal of greying using Epitalon. Greying involves melanocyte and stem cell dysfunction, changes in melanogenesis, and oxidative stress. No direct effect of Epitalon on these hair follicle pigmentation systems has been established.
Can Epitalon Reverse Grey Hair?
There is no reliable evidence in humans that Epitalon restores the natural pigmentation of grey hair. Individual before-and-after photographs cannot demonstrate a causal relationship, as colouring, lighting, natural variations and other simultaneous interventions can affect the visible hair colour.
Does Epitalon Improve Skin Condition?
No direct clinical benefits have been confirmed. Epitalon affected telomere biology in cultured human fibroblasts, but no robust human dermatological study has demonstrated a reduction in wrinkles, increased elasticity, improved hydration or visible skin rejuvenation. [2,3]
Does Epitalon Increase Collagen Production?
A direct clinical increase in collagen production in human skin by Epitalon has not been demonstrated. Dermal fibroblasts are responsible for producing a large part of the skin's extracellular matrix, but published experiments with Epitalon on fibroblasts have focused primarily on telomerase and telomeres, rather than demonstrating an increase in collagen production in the dermis.
Is Epitalon an Anti-Ageing Peptide for the Skin?
Epitalon can be described as a peptide studied in the broader context of the biology of ageing, but describing it as a proven anti-ageing skin therapy goes beyond the available evidence. No robust controlled human studies demonstrating cosmetic skin rejuvenation following Epitalon have been established.
Are Epitalon Before and After Photos Reliable?
Before-and-after photos can document a change in a specific person's appearance, but they cannot independently prove the efficacy of Epitalon. Scientifically valuable photographic evidence requires standardised conditions, objective measurements, appropriate control groups, and the documentation of other therapies and interventions used.
Limitations of Hair and Skin Evidence
The biggest limitation is that the most popular hair and skin claims have not been directly researched.
Epitalon has actual scientific literature related to ageing, but its experimental endpoints usually concern telomerase, telomeres, chromatin, melatonin, gene expression, retinal biology or animal ageing, rather than scalp hair growth or cosmetic effects on the skin.
Another limitation is mechanistic extrapolation. Hair and skin ageing involve telomere biology and cellular senescence, but these are only parts of much more complex biological systems. Hair follicles depend on stem cell niches, melanocytes, dermal papilla cells, hormonal signalling, and growth factors. Skin ageing furthermore involves extracellular matrix fragmentation, fibroblast mechanobiology, UV damage, inflammatory signalling, and tissue remodelling.
Thirdly, evidence from human cells should not be described as human clinical evidence. Human-derived fibroblasts are biologically relevant experimental models, but in vitro experiments on fibroblasts are not the same as a clinical study on skin.
Fourthly, hair pigmentation and hair growth should remain separate endpoints. Human studies showing that white hair can continue to grow indicate that the loss of pigment does not necessarily mean impaired follicle growth.
Fifthly, evidence for the pharmacological reversal of greying is also limited outside the literature concerning Epitalon. Current research continues to highlight an incomplete understanding of the mechanisms of greying and a lack of well-validated interventions that reliably restore natural pigmentation.
Therefore, the available data does not support presenting Epitalon as a proven treatment for hair regrowth, greying, androgenetic alopecia, or cosmetic skin rejuvenation.
Disclaimer
This article is for educational and scientific-information purposes only. It does not constitute medical advice, dermatological recommendations, dosage instructions, or a recommendation for the use of Epitalon.
Epitalon/Epithalon (AEDG; Ala-Glu-Asp-Gly) remains an experimental compound for the discussed applications. Controlled human studies have not demonstrated the efficacy of Epitalon in hair regrowth, the treatment of androgenetic alopecia, the reversal of greying, wrinkle reduction or cosmetic skin rejuvenation. Hair loss or unexpected pigmentation changes may have medical causes and should be evaluated by a suitably qualified specialist.
References
[1] Araj, S. K., Brzezik, J., Mądra-Gackowska, K., & Szeleszczuk, Ł. (2025). Overview of Epitalon—Highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences, 26(6), 2691. https://doi.org/10.3390/ijms26062691
[2] Khavinson, V. K., Bondarev, I. E., & Butyugov, A. A. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135(6), 590–592. https://doi.org/10.1023/A:1025493705728
[3] Al-Dulaimi, S., Thomas, R., Matta, S., & Roberts, T. (2025). Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 26(5), Article 178. https://doi.org/10.1007/s10522-025-10315-x
[4] Ji, J., Ho, B. S.-Y., Qian, G., Xie, X.-M., Bigliardi, P. L., & Bigliardi-Qi, M. (2017). Aging in hair follicle stem cells and niche microenvironment. Journal of Dermatology, 44(10), 1097–1104. https://doi.org/10.1111/1346-8138.13897
[5] Choi, H. I., Choi, G. I., Kim, E. K., Choi, Y. J., Sohn, K. C., Lee, Y., Kim, C. D., Yoon, T. J., Sohn, H. J., Han, S. H., Kim, S., Lee, J. H., & Lee, Y. H. (2011). Hair greying is associated with active hair growth. British Journal of Dermatology, 165(6), 1183–1189. https://doi.org/10.1111/j.1365-2133.2011.10625.x
[6] Yale, K., Juhasz, M., & Atanaskova Mesinkovska, N. (2020). Medication-induced repigmentation of grey hair: A systematic review. Skin Appendage Disorders, 6(1), 1–10. https://doi.org/10.1159/000504414
[7] Kumar, A. B., Shamim, H., & Nagaraju, U. (2019). Premature greying of hair: Review with updates. International Journal of Trichology. Related review: https://doi.org/10.1111/jocd.13000
[8] Fisher, G. J., & colleagues. (2023). Skin aging from the perspective of dermal fibroblasts: The interplay between adaptation to the extracellular matrix microenvironment and cell-autonomous processes. Journal of Cell Communication and Signaling. https://doi.org/10.1007/s12079-023-00743-0
[9] Cole, M. A., Quan, T., Voorhees, J. J., & Fisher, G. J. (2018). Extracellular matrix regulation of fibroblast function: Redefining our perspective on skin ageing. Journal of Cell Communication and Signaling, 12, 35–43. https://doi.org/10.1007/s12079-018-0459-1
[10] Takaya, K., Asou, T., & Kishi, K. (2023). Identification of apolipoprotein D as a dermal fibroblast marker of human ageing for development of skin rejuvenation therapy. Rejuvenation Research. https://doi.org/10.1089/rej.2022.0056